Cross-fund · 5 holders
AVTX
AVALO THERAPEUTICS INC
CUSIP 05338F306
5
Tracked holders
$49.5M
Aggregate value
3,143,327
Shares
5
Active funds
Funds holding AVTX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $14.6M | — | +111,447 | +16.1% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $13.7M | 0.02% | +288,640 | +46.0% |
| Millennium | Multi-Strategy | Q1 2026 | $12.5M | 0.01% | +175,505 | +26.6% |
| BlackRock | Institutional | Q1 2026 | $4.9M | — | +37,511 | +13.0% |
| Citadel | Multi-Strategy | Q1 2026 | $3.9M | — | -158,956 | -37.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.